Trial Profile
A dendritic cell cancer vaccine study in cancer patients from South Africa
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 25 Aug 2014
Price :
$35
*
At a glance
- Drugs Dendritic cell vaccine-Bioclones (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 25 Aug 2014 New trial record